Keynote Lecture

Advances in Lung Cancer

Solange Peters

President ESMO, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Early stage lung cancer: challenge and opportunity

Haiquan Chen

Fudan University, Shanghai, China

Neoadjuvant and adjuvant strategies in NSCLC

Enriqueta Felip

Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

A focus on emerging paradigms in the treatment of early NSCLC

Jair Bar

Chaim Sheba Medical Center, Ramat Gan, Israel

IO in combination: the SPRING trial tri-therapy approach

Benjamin Solomon

Avera Cancer Institute, Sioux Falls, USA

New drugs for SCLC

Fiona Blackhall

The Christie and Manchester Cancer Research Centre, Manchester, UK

First WIN International Molecular Tumor Board

Introduction

Patients' cases presentation by investigators. Discussion and treatment recommendation

Moderator

Razelle Kurzrock

WIN Cosortium, Villejuif, France

Panel Discussion and Q&A from the audience

Opening Keynote Lecture

The BIG AURORA molecular screening program for metastatic breast cancer: first results

Martine Piccart

Institut Jules Bordet, Brussels, Belgium

Keynote Lecture

Novel CRC insights based on combined genomic and
transcriptomic data at both bulk and single cell level, leading to new therapeutically relevant CRC classification

Sabine Tejpar

University of Leuven, Belgium

Serial profiling in metastatic CRC; beyond the tip of the
iceberg

Gerald Batist

Segal Cancer Centre, Lady Davis Institute at the JGH, McGill
University, Montréal, Canada

Paradigm shift in treatment of ovarian cancers

Susan Galbraith

AstraZeneca, USA

Novel strategies in head & neck cancers

Christophe Le Tourneau

Institut Curie, Paris, France

Expanding Precision Oncology across tumor types: advances in prostate cancer

Joaquín Mateo

Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Pediatric European Precision Cancer Medicine Program -
Facing cancer complexity

Birgit Georger

Gustave Roussy, Villejuif, France
ITCC